|
301
|
|
|
Hyaluronidase 1 |
HYAL-1, LUCA1, MPS9, NAT6 |
|
|
302
|
|
|
Hydroxycarboxylic acid receptor 2 |
GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g |
|
|
303
|
|
|
Hephaestin like 1 |
HJDD, ZP |
|
|
304
|
|
|
Hyperpolarization activated cyclic nucleotide gated potassium channel 1 |
BCNG-1, BCNG1, DEE24, EIEE24, GEFSP10, HAC-2 |
Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Breast carcinoma, Cerebral atrophy, Clonic seizures, Cortical dysplasia, Development disorder, Developmental delay, Developmental regression, Dwarfism, Dyscognitive seizures, Dyskinetic syndrome, Epilepsy, Epilepsy with febrile seizures plus, Epileptic encephalopathy, Febrile seizures, Gastroesophageal reflux disease, Generalized epilepsy with febrile seizures plus, Hypodontia, Hypotonic seizures, Impaired cognition, Jacksonian seizure, Mental depression, Mental retardation, Microcephaly, Myoclonic seizures, Non-specifi epileptic encephalopathy, Nystagmus, Obtundation status, Optic atrophy, Ptosis, Rubral tremor, Schizophrenia, Seizure, Spasms x-linked, Status epilepticusView all (22 more) |
|
305
|
|
|
Major histocompatibility complex, class I, V (pseudogene) |
HLA-75, dJ377H14.4 |
|
|
306
|
|
|
H1.9 linker histone, pseudogene |
H1-9, H1.9, HILS1 |
|
|
307
|
|
|
H2A clustered histone 9, pseudogene |
H2AFUP, HIST1H2APS3, dJ34B20.8 |
|
|
308
|
|
|
H1.12 linker histone, cluster member, pseudogene |
H1F6P, HIST1H1PS1, dJ34B20.16 |
|
|
309
|
|
|
Hes family bHLH transcription factor 5 |
bHLHb38 |
|
|
310
|
|
|
HOXD antisense growth-associated long non-coding RNA |
HOXD-AS1, MIR7704HG, Mdgt, STEEL |
|
